Patwari Pharma: The Pioneers of Pharma Distribution Model Devoid of Any Middlemen

Navneet Agarwal, Director , Sumeet Agarwal, CEO & Chairman

Navneet Agarwal, Director

Sumeet Agarwal, CEO & Chairman

Renowned the world over as the ‘Pharmacy of the World’, the Indian pharma industry constitutes to over 20 percent of the global pharma supply chain and caters to around 60 percent of the global demand for vaccines. Standing true to its fame, India deferred all odds and supplied essential medical supplies and vaccines to numerous countries across the world during COVID-19 despite the diverse logistical and supply chain hassles put forth by the pandemic.

The Indian government's numerous initiatives and incentive programs such as PLI and Make in India have served as the key drivers of the sector, wherein according to IBEF, the Indian pharma industry which is currently worth $65 billion is expected to amount to $130 billion by 2030 and further grow up to $450 billion by 2047. Standing as the key pillars of strength for Indian pharmaceuticals are the pharma distribution companies that are helping them maintain a strong supply chain globally at all times. Among the myriads of distributors that are currently operational in the country, one that stands a notch higher than the rest through its unique & pioneer approach to pharmaceutical distribution is Secunderabad-based Patwari Pharma.

Holding over six decades of experience in the pharma sector, Jai Prakash Agarwal (Advisor), along with his sons Navneet Agarwal (Director) and Sumeet Agarwal (Chairman & CEO) established Patwari Pharma in 1993 with a vision to bridge the discrepancies that existed in pharma distribution, especially in terms of delivery times to the clients. As an ISO 9001:2015 certified company, Patwari Pharma has earned the reputation of being among the most reliable suppliers and distributors of a wide range of pharma products such as Brand Name Drugs, Generic Medicine, Vaccines, Medical Devices, Ayurveda Products, and Household Chemicals, to name a few. Some of its key customers include prominent retail pharmacies, clinics, hospitals, institutions, laboratories, and many others.

“Unlike today, it was extremely difficult back then for a new player to enter into market due to the harsh opposition from existing players. Despite all the difficulties, we stuck to our instincts, brainstormed day & night, and came up with a distinctive distribution model that not only helped us succeed in our business but also ensured our customers’ satisfaction. Strongly believing that We believe every Indian has the right to get access to high-quality health and human services, we aim to provide efficient pharma distribution services and ensure to put our clients at the center of every decision”, says Navneet.

Distinctive Business Model

Under the aegis of Jai Prakash, Patwari Pharma has garnered widespread recognition in the Indian pharma community for its futuristic distribution model. Initially, the company followed the usual practice of having booking boys take orders from customers every morning, but then observed that it would be 8 or 9 pm every day by the time they returned to the shop and the stock was supplied to the customers. Thus, the firm decided to let go of the booking boys and started taking orders directly from the customers who were asked to place the order the previous night. Patwari Pharma then enlisted a group of 40-50 auto drivers who used to collect the orders from the company shop early morning and deliver them to the customers right at the time they began their business for the day. As an icing on the cake, since the commissions being paid to the middlemen were removed completely, the company also started providing its customers with attractive discounts as well, thus becoming one of the most sought-after pharma distributors in the market.

“I am proud to say that we’re the pharma distribution company in India that has no middlemen. Although many organizations tried to adopt our distribution model, they were unable to fully replicate our modus operandi. To ensure timely delivery of products to our customers, we also have a backup team of auto drivers in place who are immediately assigned with the task of supplying to a particular client at the exact same time it was scheduled. This way, we made sure that our customers get the products delivered right at the beginning of their daily business hours!”, proudly says Navneet.

Patwari Pharma bridges gaps in pharma distribution, ensuring timely delivery and customer satisfaction through innovative, middleman-free logistics

Navneet Agarwal, Director , Sumeet Agarwal, CEO & Chairman

Customer-centricity – The Core USP

Always prioritizing customer satisfaction & experience above everything else, Patwari Pharma leaves no stone unturned to ensure that its customers get nothing but quality service and value for their money. Unlike other distributors who provide one round of supplies, the company provides at least 2-3 deliveries to each customer as per their orders. While most retail pharmacies maintain at least 10-15 days of stock and spend hefty monies on their storage and inventory management, Patwari Pharma educates its customers to only maintain 4-5 days of stock owing to its efficient supply of products and invest their money on their other critical business aspects such as technology.

Well aware of the temperature-sensitive nature of certain pharmaceutical drugs, Patwari Pharma makes sure to check the temperature of such products once they reach its warehouse and then stores them in the walk-in coolers. These cold chain products are only removed from cold storage just 30 minutes before the stock is shipped to the customers. Further, it not only packs such goods in cold packs and puts them in thermocol boxes, but also prioritizes the supply of those products so that they reach the customers in the best condition. Going a step further, the company not only has call center lines to assist its clients but also a dedicated 4-member customer service team that solves all queries/grievances through WhatsApp and even places a specific phone number on which its long-term customers can directly contact them on and get their queries solves in a timely manner.

“Last year, we invested over Rs.1 crore on the Storetrack software through which our customers are able to get realtime updates and track the status of their order through their smartphones – right from placing the order to get it delivered to their doorstep. Integrated with a mobile application, the software not only enabled customers to check their available credit balance but also clearly mentioned any goods that they were returning so that we could cross-verify them with the inputs from our auto drivers and delivery agents. As a result, we have been able to maintain a high level of trust and transparency with our customers”, Jayesh Agarwal - Director, further explains.

Future Prospects

Having started its operations in Pune one and half years back, Patwari Pharma has recently acquired 130 retail outlets of Aditya Pharmacy and 10 outlets of Mitra Pharmacy across four states. Speaking more on this Jayesh Agarwal, the Director adds, "Through this strategic move, we plan to further strengthen our distribution network and fulfill priority orders from those regions with stocks available in those outlets. Additionally, our company will also be entering Jaipur over the next 2-3 months where the warehouse is already finalized and the interiors are being worked on. Overall, our firm plans to expand its geographical footprint to 5-6 new cities over the next five years".

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.